Quick Answer
FILANA THERAPEUTICS, INC. reported Earnings Per Share Diluted of $1.88 (loss) per share for the year ending 2025.
- FILANA THERAPEUTICS, INC. showed a decrease of -28.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from FILANA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2011 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $0.01 (loss) per share | Q2 2013: $0.01 (loss) per share | Q3 2013: $0.02 (loss) per share | Q4 2013: $0.72 per share | Q1 2022: $0.44 (loss) per share | Q2 2022: $0.48 (loss) per share | Q1 2023: $0.58 (loss) per share | Q2 2023: $0.63 (loss) per share | Q3 2023: $0.61 (loss) per share | Q1 2024: $0.43 (loss) per share | Q2 2024: $0.13 per share | Q3 2024: $0.58 (loss) per share | Q1 2025: $0.48 (loss) per share | Q2 2025: $0.92 (loss) per share | Q3 2025: $0.22 (loss) per share.
- Over the full 9 years of available data (2011 to 2025), FILANA THERAPEUTICS, INC.'s Earnings Per Share Diluted has declined by 3,033.3%.
- Historical annual values: Fiscal year 2025: $1.88 (loss) per share | Fiscal year 2024: $1.46 (loss) per share | Fiscal year 2023: $2.32 (loss) per share | Fiscal year 2022: $1.90 (loss) per share | Fiscal year 2015: $0.31 (loss) per share | Fiscal year 2014: $0.27 (loss) per share | Fiscal year 2013: $0.70 per share | Fiscal year 2012: $0.08 (loss) per share | Fiscal year 2011: $0.06 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: